TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Immunogenicity and Safety of Heterologous Versus Homologous Prime-Boost Regimens With BBIBP-CorV and Ad26.COV2.S COVID-19 Vaccines: A Multicentric, Randomized, Observer-Blinded Non-inferiority Trial in Madagascar and Mozambique.

Patrícia Ramgi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.